Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Observational 1 Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 58 Neoplasm Metastasis 24 Stomach Neoplasms 12 Carcinoma, Non-Small-Cell Lung 11 Colorectal Neoplasms 10 Neoplasms 8 Brain Neoplasms 7 Triple Negative Breast Neoplasms 5 Adenocarcinoma 5 Recurrence 3 Ovarian Neoplasms 3 Esophageal Neoplasms 3 Endometrial Neoplasms 3 Advanced Solid Tumor 3 Salivary Gland Neoplasms 2 Pancreatic Neoplasms 2 Meningeal Carcinomatosis 2 HER2-positive Breast Cancer 2 Colonic Neoplasms 2 Breast Cancer With Brain Metastasis 2 Adenocarcinoma Of Esophagus 2 Uterine Neoplasms 1 Unresectable Locally Recurrent Breast Cancer 1 Solid Cancer 1 Sarcoma 1 Rectal Neoplasms 1 Prostatic Neoplasms 1 Parkinson Disease 4, Autosomal Dominant Lewy Body 1 Osteosarcoma 1 Neoplasm, Residual 1

Interventions

Fulvestrant 18 Letrozole 8 Anastrozole 6 Capecitabine 5 palbociclib 4 olaparib 4 Paclitaxel 4 Goserelin 4 Docetaxel 4 pyrotinib 3 exemestane 3 Injections 3 toripalimab 2 sacituzumab govitecan 2 ribociclib 2 eribulin 2 elacestrant 2 abemaciclib 2 Vinorelbine 2 Trastuzumab 2 FCN-437c 2 Everolimus 2 Dasatinib 2 Aromatase Inhibitors 2 Alpelisib 2 Albumin-Bound Paclitaxel 2 AZD9833 2 vandetanib 1 trastuzumab deruxtecan 1 talazoparib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Advanced Breast Cancer × trastuzumab deruxtecan × Clear all

NCT06486883 2026-04-02

PONTIAC

MedSIR

Phase 2 Recruiting

Advanced Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡